Sorry to be late in responding. The news article I saw on GWPH was dated 2-21 on my TDA website. The headline was GWP42006 in adult patient with focal seizures did not meet its primary end point and stock dropped significantly since. I only brought this up as GWPH is the showcase drug co. using CDB.